GlobeNewswire - Patents

Sequana Medical Announces Granting of Key alfapump DSR? Patents in U.S. and Europe

Thu, 04 Feb 2021 06:00 GMT

GHENT, Belgium, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Sequana Medical NV (Euronext Brussels: SEQUA), an innovator in the treatment of diuretic-resistant fluid overload in liver disease, malignant ascites and heart failure, today announces the granting of key patents for the alfapump DSR (Direct Sodium Removal) programme in the U.S. and European Union.

UIC Law Student Destinee Burrell Helps Publish Patent Jury Instruction Handbook

Wed, 03 Feb 2021 20:00 GMT

Chicago, Illinois, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Destinee Burrell, a third-year student at UIC John Marshall Law School in Chicago, was one of three law students in the country who assisted with research and updates for the 2020-21 Patent Jury Instruction Handbook. The Handbook?provides a comprehensive sampling of annotated jury instructions used in actual patent infringement actions.

Bubblr Receives Notice of Allowance for U.S. Patent Application Covering ‘Internet-Based Search Mechanism’

Wed, 03 Feb 2021 13:32 GMT

Significant Milestone is Expected to Advance Company Mission to Fix Fundamental Flaws in the Current Internet Economic Model

Enzo Announces Issuance of U.S. Patent for Polyclonal Antibodies Against Osteoporosis Drug Target Sclerostin

Wed, 03 Feb 2021 13:30 GMT

NEW YORK, NY, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, today announced the recent issuance of U.S. Patent No. 10,899,827 entitled “Antibodies Specific for Sulfation Sites of Sclerostin”.

eSight Receives Key Patents for Augmenting Sight Related to its Enhanced Vision Platform

Wed, 03 Feb 2021 13:00 GMT

Patents affirm the continued innovation and commitment to improving quality of life for individuals with low vision and legal blindness

Patents affirm the continued innovation and commitment to improving quality of life for individuals with low vision and legal blindness

CHF Solutions Submits Patent Application for New and Improved Diagnostic Parameters to Support Hemodynamic Stability

Wed, 03 Feb 2021 13:00 GMT

EDEN PRAIRIE, Minn., Feb. 03, 2021 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced the submission of a patent application to increase monitoring capabilities with its Aquadex SmartFlow? system. The new technology is intended to provide clinicians with additional patient output data to inform treatment approaches and improve patient outcomes.

Corsair announces favorable verdict in Ironburg Inventions Ltd. v. Valve Corp

Tue, 02 Feb 2021 21:20 GMT

FREMONT, Calif., Feb. 02, 2021 (GLOBE NEWSWIRE) -- Corsair Gaming, Inc.?(NASDAQ:CRSR) (“Corsair”), a leading global provider and innovator of high-performance gear for gamers and content creators and its subsidiaries Scuf Gaming and Ironburg Inventions Ltd., announce that on February 1, 2021 in the patent infringement case, Ironburg Inventions Ltd. v. Valve Corp, US District Court for the Western District of Washington in Seattle the jury unanimously found that Valve Corp infringed Ironburg’s 8,641,525 controller patent and awarded Ironburg over $4 million. In addition, the jury unanimously found willful infringement by Valve Corp. The jury verdict of willful infringement is the first step to a potential award of enhanced damages up to the statutory limit of treble damages.

Skinopathy Files Provisional Patent for Artificial Intelligence and Augmented Reality Powered Technology that will Guide Skin Cancer Surgeries

Tue, 02 Feb 2021 15:30 GMT

TORONTO, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Skinopathy, a Canadian medical company founded in 2020, has filed a provisional patent with the United States Patent and Trademark Office (USPTO) for Artificial Intelligence (AI) and Augmented Reality (AR) technology that will help guide surgeons when performing skin cancer excisions.

PENNEXX Has Submitted Its Formal Patent Application for the YourSocialOffers.com Technology

Tue, 02 Feb 2021 15:16 GMT

Philadelphia, PA, Feb. 02, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire?– Pennexx (PNNX)?has submitted to the United States Patent?Trademark?Office its formal application for?"Systems and Methods for Running Social Media Marketing Campaigns."?This application claims the benefit of?U.S. Provisional Patent Application Serial No. 62/967,679?filed in?2020 and covers aspects of?Pennexx's?http://yoursocialoffers.com?social media merchant marketing?technology.

BetterLife Files Patent Protection on Dihydrohonokiol-B for Treatment of Anxiolytic Use Disorder

Tue, 02 Feb 2021 13:30 GMT

Vancouver, Feb. 02, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR /?OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development and commercialization of cutting-edge treatments in mental disorders and viral infections, announces it has filed patent protection on the newest compound to enter its pipeline, dihydrohonokiol-B (“TD-010”).? Specifically, BetterLife has filed for patent protection for the use of TD-010 as a treatment for sedative, hypnotic, or anxiolytic use disorder.

AnPac Bio Granted a New US patent on Novel Medical Device for Multi-Cancer Detection

Mon, 01 Feb 2021 12:30 GMT

Continues to Innovate and Build Strong IP Portfolio

Continues to Innovate and Build Strong IP Portfolio

UCLOUDLINK GROUP INC. Announces Investment in iQsim (Open Virtual SIM Platform Provider) and changes to Senior Management Roles

Mon, 01 Feb 2021 08:02 GMT

HONG KONG, Feb. 01, 2021 (GLOBE NEWSWIRE) -- UCLOUDLINK GROUP INC. ("UCLOUDLINK" or the “Company”) (NASDAQ: UCL), the world's first and leading mobile data traffic sharing marketplace, announced recent investment in iQsim, the leading provider of open virtual SIM (VSIM) platform and VSIM-enabled mobile devices based in France, through its Singapore subsidiary uCloudlink (Singapore) Pte. Ltd. (“Singapore UCLOUDLINK”) and UCLOUDLINK’s recent changes to its senior management roles.

DarkPulse Completes Name Change of its Patents to Reflect Company Brand

Fri, 29 Jan 2021 14:00 GMT

DarkPulse updates patent ownership information to aid in the marketing of its products

DarkPulse updates patent ownership information to aid in the marketing of its products

Mass General Brigham launches community health vans

Wed, 27 Jan 2021 15:19 GMT

Partners with local business hard hit by COVID-19

Partners with local business hard hit by COVID-19

Aqua Metals Submits Provisional Patent for New Capability Streamlining Link from AquaRefining to Battery Manufacturing

Wed, 27 Jan 2021 13:00 GMT

Expected to Create Key Active Battery Material Directly from AquaRefining

Anaqua Successfully Completes SOC 2 Examination

Tue, 26 Jan 2021 14:05 GMT

Leading IP management solutions provider demonstrates strength of commitment to information and systems security

Leading IP management solutions provider demonstrates strength of commitmentto information and systems security

Precision BioSciences Receives Notice of Allowance for U.S. Patent Application Covering PBCAR19B, a Stealth Cell, CD19 Allogeneic CAR T Candidate for Non-Hodgkin Lymphoma

Mon, 25 Jan 2021 12:00 GMT

DURHAM, N.C., Jan. 25, 2021 (GLOBE NEWSWIRE) -- Precision BioSciences, Inc. (Nasdaq: DTIL) a clinical stage biotechnology company dedicated to improving life with its wholly proprietary ARCUS^? genome editing platform, today announced it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a patent application covering PBCAR19B, a next-generation, stealth cell, CD19 product candidate for patients with relapsed/refractory (R/R) Non-Hodgkin Lymphoma (NHL).

Milestone Scientific Inc. Receives Notice of Allowance for U.S Patent Related to CompuFlo? Disposables

Wed, 20 Jan 2021 20:00 GMT

ROSELAND, N.J., Jan. 20, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today announced that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for a patent relating to the disposable component of Milestone’s CompuFlo? Instrument.

PureCircle und Almendra legen Patentstreit in den USA bei

Wed, 20 Jan 2021 19:41 GMT

CHICAGO, Jan. 20, 2021 (GLOBE NEWSWIRE) -- PureCircle und Almendra haben in einem Patentstreit in den USA über die Verwendung der Steviarome?-Produkte von Almendra einen gütlichen Vergleich geschlossen.

PureCircle與Almendra的美國專利訴訟案結案

Wed, 20 Jan 2021 19:41 GMT

芝加哥, Jan. 21, 2021 (GLOBE NEWSWIRE) -- PureCircle與Almendra在有關Almendra的Steviarome?產品及其使用的美國專利糾紛案中達成友好和解。